Transcriptomics

Dataset Information

0

Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA207]

ABSTRACT: Integration of in silico and in vitro approaches to design and conduct transcriptomic drug screening in patient-derived neural cells, in order to survey novel pathologies and points of intervention in schizophrenia.

ORGANISM(S): Homo sapiens

PROVIDER: GSE119289 | GEO | 2018/10/31

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA206]
2018-10-31 | GSE119288 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA205]
2018-10-31 | GSE119287 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA204]
2018-10-31 | GSE119286 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA203]
2018-10-31 | GSE119285 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA202]
2018-10-31 | GSE119284 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA201]
2018-10-31 | GSE119283 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA108]
2018-10-31 | GSE119282 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA107]
2018-10-31 | GSE119281 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA106]
2018-10-31 | GSE119280 | GEO
Transcriptomics Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [MSA105]
2018-10-31 | GSE119279 | GEO